|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C12N 15/63 | (2006.01) |
| C12N 15/861 | (2006.01) | ||
| A61K 48/00 | (2006.01) |
| (11) | Number of the document | 3411484 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17747935.9 |
| Date of filing the European patent application | 2017-01-25 | |
| (97) | Date of publication of the European application | 2018-12-12 |
| (45) | Date of publication and mention of the grant of the patent | 2023-10-04 |
| (46) | Date of publication of the claims translation | 2023-11-27 |
| (86) | Number | PCT/US2017/014914 |
| Date | 2017-01-25 |
| (87) | Number | WO 2017/136202 |
| Date | 2017-08-10 |
| (30) | Number | Date | Country code |
| 201662292157 P | 2016-02-05 | US |
| (72) |
DONSANTE, Anthony , US
KOZARSKY, Karen , US
BOULIS, Nicholas Matthew , US
RILEY, Jonathan Patrick , US
|
| (73) |
Emory University ,
1599 Clifton Road NE
4th Floor, Atlanta, GA 30322,
US
REGENXBIO Inc. , 9804 Medical Center Drive, Rockville, MD 20850, US |
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Viengrandžio arba sau pačiam komplementaraus adeno-asocijuoto viruso 9 injekcija į smegenų skystį |
| INJECTION OF SINGLE-STRANDED OR SELF-COMPLEMENTARY ADENO-ASSOCIATED VIRUS 9 INTO THE CEREBROSPINAL FLUID |
| Payment date | Validity (years) | Amount | |
| 2025-01-20 | 9 | 208.00 EUR |
| 2026-01-25 |